Publications

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials.

Early Breast Cancer Trialists’ Collaborative group (EBCTCG) ., (2021), Lancet Oncol, 22, 1139 - 1150

Locoregional recurrence after neo-adjuvant chemotherapy (NACT) for early breast cancer: a literature review

Tyagi S. et al, (2020), BREAST CANCER RESEARCH AND TREATMENT, 180, 558 - 558

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) ., (2019), Lancet, 393, 1440 - 1452

Psychological interventions for coronary heart disease: Cochrane systematic review and meta-analysis.

Richards SH. et al, (2018), Eur J Prev Cardiol, 25, 247 - 259

Transcatheter aortic valve implantation for aortic stenosis in high surgical risk patients: A systematic review and meta-analysis.

Liu Z. et al, (2018), PLoS One, 13

dverse effects of extracorporeal carbon dioxide removal (ECCO2R) for acute respiratory failure: a systematic review protocol.

Liu Z. et al, (2016), Syst Rev, 5

Dasatinib and nilotinib for imatinib-resistant or -intolerant chronic myeloid leukaemia: a systematic review and economic evaluation.

Rogers G. et al, (2012), Health Technol Assess, 16, 1 - 410

Cost-effectiveness of dasatinib and nilotinib for imatinib-resistant or -intolerant chronic phase chronic myeloid leukemia.

Hoyle M. et al, (2011), Value Health, 14, 1057 - 1067

Cost-effectiveness of temsirolimus for first line treatment of advanced renal cell carcinoma.

Hoyle M. et al, (2010), Value Health, 13, 61 - 68

Cost-effectiveness of sorafenib for second-line treatment of advanced renal cell carcinoma.

Hoyle M. et al, (2010), Value Health, 13, 55 - 60

Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation.

Thompson Coon J. et al, (2010), Health Technol Assess, 14, 1 - iv

Reply: SUN vs BEVþIFN in first-line mRCC therapy: no evidence for a statistically significant difference in progression-free survival

Thompson Coon JS. et al, (2010), British Journal of Cancer, 102, 234 - 235

The effectiveness and cost-effectiveness of cochlear implants for severe to profound deafness in children and adults: a systematic review and economic model.

Bond M. et al, (2009), Health Technol Assess, 13, 1 - 330

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.

Shepherd J. et al, (2008), Health Technol Assess, 12, iii - 360

Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.

Connock M. et al, (2007), Health Technol Assess, 11, 1 - iv

Search results (16)